This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Polygonum cuspidatum is a medicinal plant rich in resveratrol and other bioactive phenolics used in traditional medicine for inflammatory and metabolic conditions [PMID:36620922, PMID:37241822].
Background
Polygonum cuspidatum Sieb. et Zucc (Polygonaceae), also known as 'Huzhang', is a medicinal plant and vegetable distributed in China, Korea, and Japan [PMID:36620922, PMID:38513776]. Its dried roots and rhizomes are listed in the Chinese Pharmacopoeia [PMID:36620922, PMID:24194779].
Traditional uses
Used in traditional Chinese medicine to treat inflammation, hyperlipemia [PMID:36620922], cough, hepatitis, jaundice, amenorrhea, leucorrhea, arthralgia, burns, and snake bites [PMID:24194779]. It is also used for clearing heat, eliminating dampness, draining the gallbladder to relieve jaundice, removing blood stasis to alleviate pain, and resolving phlegm [PMID:34719206].
Active compounds
The plant contains flavonoids, anthraquinones, and stilbenes [PMID:36620922]. Key bioactive constituents include resveratrol (3,5,4'-trihydroxystilbene) [PMID:22432802], polydatin (resveratrol-O3-beta-glucoside) [PMID:39334769], and emodin [PMID:27188216].
Mechanism of action
Resveratrol acts via cell apoptosis, antiproliferation, and anti-inflammation [PMID:22432802], and inhibits protein-tyrosine kinase (p56lck) [PMID:8277318]. Polydatin increases oxidative phosphorylation (OXPHOS) efficiency to reduce reactive oxygen species (ROS) [PMID:39334769]. Emodin inhibits NLRP3 inflammasome activation by promoting FUNDC1-mediated mitophagy and suppressing CK2-mediated phosphorylation of FUNDC1 [PMID:40520006].
Clinical evidence
Evidence ACancer
Resveratrol is believed to work as a chemopreventive agent by inducing apoptosis and suppressing cell proliferation [PMID:22432802, PMID:25788047]
Evidence CCardiovascular Disease
Resveratrol and polydatin exert cardioprotective effects by regulating lipid metabolism and reducing oxidative stress [PMID:25151891, PMID:32480216]
Evidence CLiver Injury
Polydatin, resveratrol, and emodin alleviate cholestatic liver injury by regulating bile-acid synthesis via FXR, PXR, and BSEP, and activating Nrf2-dependent antioxidant defenses [PMID:41106787]
Evidence DInflammatory Pain
Alcohol extract of P. cuspidatum exerts analgesic effects via the MAPK/ERK signaling pathway in mouse models [PMID:37876500]
Evidence DKidney Injury
Polydatin protects against ischemia-reperfusion-induced acute kidney injury by inhibiting SETD2-mediated ferroptosis in mice [PMID:41083610]
Evidence D
Safety & adverse effects
Emodin, a constituent of P. cuspidatum, may lead to hepatotoxicity, kidney toxicity, and reproductive toxicity, particularly with high doses and long-term use [PMID:27188216].
Evidence summary
Evidence ranges from high-level systematic reviews for anticancer potential to preclinical animal and in vitro studies for organ-specific protective effects (kidney, liver, lung).
PubMed sources
1.PMID: 27188216 (2016) — Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics. · Phytotherapy research : PTR
3.PMID: 40520006 (2025) — Emodin Inhibits NLRP3 Inflammasome Activation and Protects Against Sepsis via Promoting FUNDC1-Mediated Mitophagy. · International journal of biological sciences
4.PMID: 36620922 (2023) — Advances for pharmacological activities of Polygonum cuspidatum - A review. · Pharmaceutical biology
5.PMID: 33459060 (2021) — Bioactive amides from Polygonum cuspidatum. · Journal of Asian natural products research
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
7.PMID: 39334769 (2024) — Senescence Rejuvenation through Reduction in Mitochondrial Reactive Oxygen Species Generation by Polygonum cuspidatum Extract: In Vitro Evidence. · Antioxidants (Basel, Switzerland)
8.PMID: 22432802 (2012) — Resveratrol: potential as anticancer agent. · Journal of dietary supplements
9.PMID: 41106787 (2025) — Protective effects of Polygonum cuspidatum bioactive constituents against cholestatic liver injury: A mechanistic review. · Fitoterapia
10.PMID: 25151891 (2014) — Resveratrol and cardiovascular health--promising therapeutic or hopeless illusion? · Pharmacological research
11.PMID: 8277318 (1993) — Kinase inhibitors from Polygonum cuspidatum. · Journal of natural products
12.PMID: 34808343 (2022) — Expression, purification and structural characterization of resveratrol synthase from Polygonum cuspidatum. · Protein expression and purification
13.PMID: 37876500 (2023) — Polygonum Cuspidatum Alcohol Extract Exerts Analgesic Effects via the MAPK/ERK Signaling Pathway. · Drug design, development and therapy
14.PMID: 38513776 (2024) — Polygonum cuspidatum polysaccharide: A review of its extraction and purification, structure analysis, and biological activity. · Journal of ethnopharmacology
15.PMID: 36304949 (2022) — Resveratrol biosynthesis, optimization, induction, bio-transformation and bio-degradation in mycoendophytes. · Frontiers in microbiology
16.PMID: 17657351 (2007) — Antioxidant activity of extract from Polygonum cuspidatum. · Biological research
17.PMID: 24194779 (2013) — A Review of the Pharmacological Effects of the Dried Root of Polygonum cuspidatum (Hu Zhang) and Its Constituents. · Evidence-based complementary and alternative medicine : eCAM
18.PMID: 37241822 (2023) — Evaluation of the Biological Properties of an Optimized Extract of Polygonum cuspidatum Using Ultrasonic-Assisted Extraction. · Molecules (Basel, Switzerland)
19.PMID: 34719206 (2021) — Effective inhibition of coronavirus replication by Polygonum cuspidatum. · Frontiers in bioscience (Landmark edition)
20.PMID: 40538533 (2025) — Polydatin-curcumin formulation alleviates CTD-ILD-like lung injury in mice via GABBR/PI3K/AKT/TGF-β pathway. · Frontiers in pharmacology
21.PMID: 34018734 (2021) — De Novo Biosynthesis of Polydatin in Saccharomyces cerevisiae. · Journal of agricultural and food chemistry
22.PMID: 25788047 (2015) — Anti-tumor effects and cellular mechanisms of resveratrol. · Drug discoveries & therapeutics
23.PMID: 38276543 (2024) — Effects of Fermented Polygonum cuspidatum on the Skeletal Muscle Functions. · Nutrients
24.PMID: 41083610 (2025) — Polydatin Alleviated Ischemia-Reperfusion Induced Kidney Injury by Inhibiting SETD2-Mediated Ferroptosis. · Phytotherapy research : PTR
25.PMID: 31836186 (2020) — Protective effects of polydatin on multiple organ ischemia-reperfusion injury. · Bioorganic chemistry
26.PMID: 36618923 (2022) — Emodin in cardiovascular disease: The role and therapeutic potential. · Frontiers in pharmacology
27.PMID: 23862567 (2013) — Polydatin: a review of pharmacology and pharmacokinetics. · Pharmaceutical biology
28.PMID: 41365191 (2026) — Polygonum cuspidatum alleviates hyperuricemia-induced renal injury via rectifying amino acid metabolism disorders. · Phytomedicine : international journal of phytotherapy and phytopharmacology
29.PMID: 42287223 (2026) — Functional Divergence of Three Segmentally Duplicated UGT71 Enzymes Reveals Distinct Glycosylation Strategies toward Resveratrol and Emodin in Polygonum cuspidatum. · Journal of agricultural and food chemistry
30.PMID: 32480216 (2020) — Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie